Effects of modified risk tobacco product claims on consumer comprehension and risk perceptions of IQOS

Author:

Yang BoORCID,Massey Zachary BORCID,Popova LucyORCID

Abstract

IntroductionTobacco industry studies on consumers’ perceptions of modified risk claims (MRCs) often had important omissions (eg, no control group, not investigating whether consumers understand what ‘switching completely’ means). This study examined the effects of IQOS MRCs on risk perceptions and behavioural intentions.MethodBased on tobacco companies’ MRCs, we manipulated three MRC language features: explanation about ‘switching completely’ (absent vs present), number of diseases (single vs multiple) and language certainty (hypothetical vs certain). In an online experiment, we randomised 1523 US adult current smokers and 1391 young adult non-smokers to 1 of 9 conditions following a 2×2×2+1 control design. People reported their comprehension of ‘switching completely’, IQOS risk perceptions and behavioural intentions after message exposure.ResultsMore smokers exposed to MRCs that included an explanation about ‘switching completely’ (22.2%) (vs explanation absent (11.2%) and control (10.7%)) mentioned that ‘switching completely’ meant smoking 0 cigarettes. Compared with the control, several MRCs (eg, certain language) produced lower perceived risk of IQOS, including for diseases not mentioned in the MRCs. MRCs using certain and hypothetical language did not differ on any outcomes. MRCs highlighting reduced risk for a single disease and multiple diseases did not differ on any outcomes. MRCs did not influence behavioural intentions.ConclusionThe Food and Drug Administration should ensure that consumers understand what ‘switching completely’ means in an MRC and recognize that some language features may mislead consumers into believing that a product reduces the risk of diseases not mentioned in an MRC.

Funder

National Institute on Drug Abuse of the National Institutes of Health and the Food and Drug Administration Center for Tobacco Products

National Cancer Institute of the National Institutes of Health and the Food and Drug Administration Center for Tobacco Products

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health(social science)

Reference47 articles.

1. U.S. Food and Drug Administration . Guidance for the industry: modified risk tobacco product applications, 2012. Available: https://www.fda.gov/media/83300/download

2. U.S. Food and Drug Administration . FDA grants first-ever modified risk orders to eight smokeless tobacco products, 2019. Available: https://www.fda.gov/news-events/press-announcements/fda-grants-first-ever-modified-risk-orders-eight-smokeless-tobacco-products

3. U.S. Food and Drug Administration . FDA authorizes marketing of IQOS tobacco heating system with ‘reduced exposure’ information, 2020. Available: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-information

4. U.S. Food and Drug Administration . Modified risk tobacco products, 2020. Available: https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-tobacco-products

5. Heat-not-burn tobacco cigarettes: smoke by any other name;Auer;JAMA Intern Med,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3